Henric Bjorn Bjarke - Net Worth and Insider Trading
Henric Bjorn Bjarke Net Worth
The estimated net worth of Henric Bjorn Bjarke is at least $285,772 dollars as of 2024-12-01. Henric Bjorn Bjarke is the SVP, COO of Inozyme Pharma Inc and owns about 80,626 shares of Inozyme Pharma Inc (INZY) stock worth over $218,496. Henric Bjorn Bjarke is also the SVP & CCO of IVERIC bio Inc and owns about 1,684 shares of IVERIC bio Inc (ISEE) stock worth over $67,276. Details can be seen in Henric Bjorn Bjarke's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Henric Bjorn Bjarke has not made any transactions after 2022-04-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Henric Bjorn Bjarke
Henric Bjorn Bjarke Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Henric Bjorn Bjarke owns 2 companies in total, including Inozyme Pharma Inc (INZY) , and IVERIC bio Inc (ISEE) .
Click here to see the complete history of Henric Bjorn Bjarke’s form 4 insider trades.
Insider Ownership Summary of Henric Bjorn Bjarke
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INZY | Inozyme Pharma Inc | 2022-04-19 | See Remarks |
| ISEE | IVERIC bio Inc | 2017-01-05 | SVP & CCO |
Henric Bjorn Bjarke Latest Holdings Summary
Henric Bjorn Bjarke currently owns a total of 2 stocks. Among these stocks, Henric Bjorn Bjarke owns 80,626 shares of Inozyme Pharma Inc (INZY) as of April 19, 2022, with a value of $218,496 and a weighting of 76.46%. Henric Bjorn Bjarke also owns 1,684 shares of IVERIC bio Inc (ISEE) as of January 5, 2017, with a value of $67,276 and a weighting of 23.54%.
Latest Holdings of Henric Bjorn Bjarke
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INZY | Inozyme Pharma Inc | 2022-04-19 | 80,626 | 2.71 | 218,496 |
| ISEE | IVERIC bio Inc | 2017-01-05 | 1,684 | 39.95 | 67,276 |
Holding Weightings of Henric Bjorn Bjarke
Henric Bjorn Bjarke Form 4 Trading Tracker
According to the SEC Form 4 filings, Henric Bjorn Bjarke has made a total of 1 transactions in Inozyme Pharma Inc (INZY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Inozyme Pharma Inc is the acquisition of 27,100 shares on April 19, 2022, which cost Henric Bjorn Bjarke around $99,999.
According to the SEC Form 4 filings, Henric Bjorn Bjarke has made a total of 0 transactions in IVERIC bio Inc (ISEE) over the past 5 years. The most-recent trade in IVERIC bio Inc is the sale of 316 shares on January 5, 2017, which brought Henric Bjorn Bjarke around $1,567.
Insider Trading History of Henric Bjorn Bjarke
- 1
Henric Bjorn Bjarke Trading Performance
GuruFocus tracks the stock performance after each of Henric Bjorn Bjarke's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Henric Bjorn Bjarke is 21.65%. GuruFocus also compares Henric Bjorn Bjarke's trading performance to market benchmark return within the same time period. The performance of stocks bought by Henric Bjorn Bjarke within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Henric Bjorn Bjarke's insider trading performs compared to the benchmark.
Performance of Henric Bjorn Bjarke
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.47 | | | | | |
| Relative Return to S&P 500(%) | 6.11 | | | | | |
Henric Bjorn Bjarke Ownership Network
Henric Bjorn Bjarke Owned Company Details
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Henric Bjorn Bjarke is the See Remarks of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and director & 10 percent owner & See Remarks Axel Bolte .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Henric Bjorn Bjarke made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , a net purchase of 833,333 shares made by Robert Lorne Hopfner , and a net sale of 7,523 shares made by Douglas A Treco .
In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 1,666,666 shares were bought by its insiders, resulting in a net purchase of 1,659,143 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
Henric Bjorn Bjarke Mailing Address
Above is the net worth, insider trading, and ownership report for Henric Bjorn Bjarke. You might contact Henric Bjorn Bjarke via mailing address: One University Square Drive, Suite 280, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
